Development of a PTEN-siRNA activated scaffold to promote axonal regrowth following spinal cord injury
This study showcases the successful development of a <i>PTEN</i>-siRNA activated scaffold for SCI repair applications. Initially, siRNA was combined with the novel non-viral glycosaminoglycan-binding enhanced transduction (GET) peptide vector (image of GET vector from [22]). The formulated GET-siRNA nanoparticles effectively transfected primary neurons, a cell type generally considered challenging to transfect. Subsequently, siRNA-nanoparticles were incorporated into a hyaluronic acid scaffold enriched with neurotrophic extracellular matrix proteins (collagen IV and fibronectin) developed by our laboratory for spinal cord repair applications. Functionalisation of these scaffolds with <i>PTEN</i>-siRNA nanoparticles significantly enhanced their capacity to promote neurite outgrowth.Image 1.
Authors
- Cian O. O'Connor
- Jack Maughan (ORCID: https://orcid.org/0000-0003-0716-2697)
- Ian Woods (ORCID: https://orcid.org/0000-0002-7889-1590)
- G Brunetti (ORCID: https://orcid.org/0000-0003-3168-4575)
- Martyna Stasiewicz
- James E. Dixon (ORCID: https://orcid.org/0000-0003-1225-3825)
- Adrian Dervan (ORCID: https://orcid.org/0000-0001-9201-276X)
- Marko Dobricic
- Tara K. McGuire
- Fergal J. O'Brien
Institutions
- University of Nottingham (GB)
- Royal College of Surgeons in Ireland (IE)
- Trinity College Dublin (IE)
- Advanced Materials and BioEngineering Research (IE)
- Nottingham Biomedical Research Centre (GB)
Publication Details
- Journal
- Bioactive Materials
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1016/j.bioactmat.2026.01.022
- Primary Topic
- Nerve injury and regeneration
- Type
- article
- Field-Weighted Citation Impact
- 0.00